[en] Dendritic cells (DC) are described as "nature's adjuvant," since they have the capacity to sensitize T cells in vivo upon first encounter with the antigen. The potent accessory properties of DC appear to develop sequentially. In particular, the ability to process antigens and to sensitize native T cells develops in sequence, a process termed "maturation" that is well described in vitro. Here, we obtain evidence for maturation in vivo in response to the bacterial product lipopolysaccharide (LPS). Before LPS treatment, many DC are found at the margin between the red and white pulp. These cells lack the M342 and DEC-205 markers, but process soluble proteins effectively. 6 h after LPS, DC with the M342 and DEC-205 markers are found in increased numbers in the T cell areas. These cells have a reduced capacity to process proteins, but show increases in the B7 costimulator and T cell stimulatory capacity. 48 h after LPS, the number of DC in the spleen is reduced markedly. We interpret these findings to mean that LPS can cause DC in the marginal zone to mature and to migrate into and then out of the T cell areas.
Thompson, C.B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell. 81:979-982.
Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248:1349-1356.
Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (Wash. DC). 257:792-795.
Linsley, P.S., W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, and J.A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-564.
Lenschow, D.J., G. Huei-Ting Su, L.A. Zuckerman, N. Nabavi, C.L. Jellis, G.S. Gray, J. Miller, and J.A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA. 90:11054-11058.
Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science (Wash. DC). 257:789-792.
Turka, L.A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R. Wei, M.L. Gibson, X. Zhen, S. Myrdal, D. Gordon et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102-11105.
Lin, H., S.F. Bolling, P.S. Linsley, R.-Q. Wei, D. Gordon, C.B. Thopmson, and L.A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4-Ig plus donor-specific transfusion. J. Exp. Med. 178:1801-1806.
Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
Inaba, K., M.D. Witmer, and R.M. Steinman. 1984. Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells, during primary antibody responses in vitro. J. Exp. Med. 160:858-876.
Kast, W.M., C.J.P. Boog, P.O. Roep, A.C. Voordouw, and C.J.M. Melief. 1988. Failure or success in the restoration of virus-specific cytotoxic T lymphocytes response defects of dendritic cells. J. Immunol. 14:3186-3193.
Macatonia, S.E., P.M. Taylor, S.D. Knight, and B.A. Askonas. 1989. Primary stimulation by dendritic cells induces anti-viral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169:1255-1264.
Steinman, R.M., B. Gutchinov, M.D. Witmer, and M.C. Nussenzweig. 1983. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J. Exp. Med. 157:613-627.
Inaba, K., J.W. Young, and R.M. Steinman. 1987. Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182-194.
Britz, J.S., P.W. Askenase, W. Ptak, R.M. Steinman, and R.K. Gershon. 1982. Specialized antigen-presenting cells: splenic dendritic cells and peritoneal exudate cells induced by mycobacteria, activate effector T cells that are resistant to suppression. J. Exp. Med. 155:1344-1356.
Macatonia, S.E., S.C. Knight, A.J. Edwards, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph nodes dendritic after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166:1654-1667.
Aiba, S., and S.I. Katz. 1990. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145:2791-2796.
Lechler, R.I., and J.R. Batchelor. 1982. Restauration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155: 31-41.
Faustman, D., R.M. Steinman, H. Geble, V. Hauptfeld, J. Davie, and P. Lacy. 1984. Prevention of rejection of murine islets allograft by pretreatment with anti-dendritic cell antibody. Proc. Natl. Acad. Sci. USA. 81:3864-3868.
Larsen, C.P., P.J. Morris, and J.M. Austyn. 1990. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J. Exp. Med. 171:307-314.
Boog, C.J.P., W.M. Kast, H. Thy, M. Timmers, J. Boes, L.P. de Waal, and C.J.M. Melief. 1985. Abolition of specific immune response defect by immunization with dendritic cells. Nature (Lond.). 318:59-62.
Inaba, K., M.T. Metlay, M.T. Crowley, and R.M. Steinman. 1990. Dendritic cells pulsed with antigens in vitro can prime antigen-specific, major histocompatibility complex-restricted T cells in situ. J. Exp. Med. 172:631-640.
Sornasse, T., V. Flamand, G. De Becker, H. Bazin, F. Tielemans, K. Thielemans, J. Urbain, O. Leo, and M. Moser. 1992. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J. Exp. Med. 175:15-21.
Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Tielemans, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605-610.
Larsen, C.P., S.C. Ritchie, T.C. Pearson, P.S. Linsley, and R.P. Lowry. 1992. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J. Exp. Med. 176:1215-1220.
Inaba, K., M. Witmer-Pack, M. Inaba, K.S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P.S. Linsley, S. Ikehara et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.
Moser, M., T. De Smedt, T. Sornasse, F. Tielemans, A.A. Chentoufi, E. Muraille, M. Van Mechelen, J. Urbain, and O. Leo. 1995. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur. J. Immunol. 25:2818-2824.
Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A.M. Livingstone, C.G. Fathman, K. Inaba, and R.M. Steinman. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169: 1169-1178.
Crowley, M.T., K. Inaba, M.D. Witmer-Pack, S. Gezelter, and R.M. Steinman. 1990. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J. Immunol. Methods. 133:55-66.
Koch, F., B. Trockenbacher, E. Kämpgen, O. Grauer, H. Stössel, A.M. Livingstone, G. Schuler, and N. Romani. 1995. Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J. Immunol. 155:93-100.
Harding, F.A., J.G. McArthur, J.A. Gross, D.H. Raulet, and J.P. Allison. 1992. CD28 mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (Lond.). 356:607-609.
Leo, O., M. Foo, D. Sachs, L.E. Samelson, and J. Bluestone. 1987. Identification of a monoclonal antibody specific from a murine T3 peptide. Proc. Natl. Acad. Sci. USA. 84:1374-1378.
Ruberti, G., K.S. Sellins, C.M. Hill, R.N. Germain, C.G. Fathman, and A. Livingstone. 1992. Presentation of antigen by mixed isotype class II molecules in normal H-2d mice. J. Exp. Med. 175:157-162.
Naquet, P., J. Ellis, B. Singh, R.S. Hodges, and T.L. Delovitch. 1987. Processing of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells. J. Immunol. 139:3955-3963.
Metlay, J.P., M.D. Witmer-Pack, R. Agger, M.T. Crowley, D. Lawless, and R.M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171: 1753-1771.
Razi-Wolf, Z., F. Galvin, G. Gray, and H. Reiser. 1993. Evidence for an additional ligand, distinct from B7, for CTLA-4 receptor. Proc. Natl. Acad. Sci. USA. 90:11182-11186.
Hathcock, K.S., G. Lazlo, H.B. Dickler, J. Bradshaw, P. Linsley, and R.J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science (Wash. DC). 262:905-907.
Crowley, M., K. Inaba, M. Witmer-Pack, and R.M. Steinman. 1989. The cell surface of mouse DC: FACS analyses of DC from different tissues including thymus. Cell. Immunol. 118:108-125.
Kraal, G., M. Breel, M. Jnase, and G. Bruin. 1986. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163: 981-997.
Agger, R., M. Witmer-Pack, N. Romani, H. Stossel, W.J. Swiggard, J.P. Metlay, E. Storozynsky, P. Freimuth, and R.M. Steinman. 1992. Two populations of splenic dendritic cells detected with M342, a new monoclonal to an intracellular antigen of interdigitating dendritic cells and some B lymphocytes. J. Leukoc. Biol. 52:34-42.
Inaba, K., W.J. Swiggard, M. Inaba, J. Meltzer, A. Mirza, T. Sasagawa, M.C. Nussenzweig, and R.M. Steinman. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163:148-156.
Bhardwaj, N., J.W. Young, A.J. Nisanian, J. Baggers, and R.M. Steinman. 1993. Small amounts of superantigens, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178:633-642.
Muraille, E., G. De Becker, M. Bakkus, K. Thielemans, J. Urbain, M. Moser, and O. Leo. 1995. Co-stimulation lowers the threshold for activation of naive T cells by bacterial superantigens. Int. Immunol. 152:5208-5219.
Leo, O., D.H. Sachs, L.E. Samelson, M. Foo, R. Quinones, R. Gress, and J.A. Bluestone. 1986. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. J. Immunol. 137:3874-3880.
Jiang, W., W.J. Swiggard, C. Heufler, M. Peng, A. Mirza, R.M. Steinman, and M.C. Nussenzweig. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature (Lond.). 375: 151-155.
Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392-399.
Kupiec-Weglinski, J.W., J.M. Austyn, and P.J. Morris. 1988. Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J. Exp. Med. 167:632-645.
Abraham, E., and R.F. Regan. 1985. The effects of hemorrhage and trauma on interleukin 2 production. Arch. Surg. 120:1341-1344.
Grbic, J.T., J.A. Mannick, D.B. Gough, and M.L. Rodrick. 1991. The role of prostaglandin E2 in immune suppression following injury. Ann. Surg. 214:253-263.
Ayala, A., Z.K. Deol, D.L. Lehman, C.D. Herdon, and I.H. Chaudry. 1994. Polymicrobial but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-γ release while increasing IL-4/IL-10 production. J. Surg. Res. 56: 579-585.
Groeneveld, P.H.P., T. Erich, and G. Kraal. 1986. The differential effects of bacterial lipopolysaccharide (LPS) on splenic non-lymphoid cells demonstrated by monoclonal antibodies. Immunology. 58:285-290.
MacPherson, G.G., C.D. Jenkins, M.J. Stein, and C. Edwards. 1995. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J. Immunol. 154:1317-1322.
Roake, J.A., A.S. Rao, P.J. Morris, C.P. Larsen, D.F. Hankins, and J.M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
Schon-Hegrad, M.A., J. Oliver, P.G. McMenamin, and P.G. Holt. 1991. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells in the conducting airways. J. Exp. Med. 173:1345-1356.
Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.
Knight, S.C., P. Bedford, and R. Hunt. 1985. The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell. Immunol. 94:435-139.
Austyn, J.M., J.W. Kupiec-Weglinski, D.F. Hankins, and P.J. Morris. 1988. Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J. Exp. Med. 167:646-651.
Heufler, C., F. Koch, and G. Schuler. 1988. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167: 700-705.
Cumberbatch, M., and I. Kimber. 1992. Dermal tumor necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration. Immunology. 75:257-263.
Cumberbatch, M., and I. Kimber. 1995. Tumor necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology. 84:31-35.
Koide, S.L., K. Inaba, and R.M. Steinman. 1987. Interleukin 1 enhances T cell-dependent immune responses by amplifying the function of dendritic cells. J. Exp. Med. 165:515-530.
Kanangat, S., S. Nair, J.S. Babu, and B.T. Rouse. 1995. Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens. J. Leukoc. Biol. 57:310-316.
Granucci, F., G. Girolomoni, M.B. Lutz, M. Foti, G. Marconi, P. Gnocchi, L. Nolli, and P. Ricciardi-Castagnoli. 1994. Modulation of cytokine expression in mouse dendritic cell clones. Eur. J. Immunol. 24:2522-2526.
Janeway, C. 1989. Immunogenicity signals 1, 2, 3 . . . and 0. Immunol. Today. 10:286-289.
Liu, Y., and C.A. Janeway. 1991. Microbial induction of costimulatory activity for CD4 T-cell growth. Int. Immunol. 3: 323-332.